Literature DB >> 569244

A sensitive solid phase radioimmunoassay for secretory IgA: its application for the determination of urinary levels of secretory IgA in children and adults.

R Shibata, K Onoue, N Goya.   

Abstract

A sensitive solid phase radioimmunoassay method was established for the specific quantitative determination of secretory IgA (sIgA) by taking advantage of the dual antigenicities of sIgA, one specific for alpha-chain and the other for secretory component (SC). The sIgA and IgA in the sample were first bound by anti-IgA antibodies coated on the polystyrene tube, then the amount of bound sIgA was quantified by the use of 125I-labeled anti-SC antibodies. This method is quite sensitive and allows us to distinguish sIgA from IgA and free SC which usually coexist in exocrine secretions. Linear relationship was observed between the bound radioactivity of radioiodinated anti-SC and the amount of sIgA in the range of 5 to 60 ng of sIgA. With this method, the urinary sIgA levels in normal children and adults were measured. Urinary sIgA was detected in half of infants within 7 days after birth, while it could be demonstrated in almost all of the infants by 14th day. Then, it gradually increased and reached about a half of the adult level by the age of puberty. This method will be useful for the sensitive and specific measurement of sIgA in various exocrine secretions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 569244     DOI: 10.1111/j.1348-0421.1978.tb00393.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

1.  Selective IgA deficiency: analysis of Ig production in vitro.

Authors:  T Inoue; H Okubo; J Kudo; T Ikuta; K Hachimine; R Shibata; O Yoshinari; K Fukada; T Yanase
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

2.  Developmental profiles of urinary SIgA in newborns and the effect of blood transfusion.

Authors:  Y Ishiguro; K Kato; T Ito; M Nagaya
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.